Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Jul-Aug;24(4):422-429.
doi: 10.4103/aja2021109.

The association between mutations in ubiquitin-specific protease 26 (USP26) and male infertility: a systematic review and meta-analysis

Affiliations
Meta-Analysis

The association between mutations in ubiquitin-specific protease 26 (USP26) and male infertility: a systematic review and meta-analysis

Qin-Yu Li et al. Asian J Androl. 2022 Jul-Aug.

Abstract

During recent decades, the association between mutations in ubiquitin-specific protease 26 (USP26) and male infertility remains doubtful. We conducted this meta-analysis to evaluate the association between mutations in USP26 and male infertility according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. It was registered in the International Prospective Register of Systematic Reviews (PROSPERO; CRD42021225251). PubMed, Web of Science, and Scopus were systematically searched for comparative clinical studies, which were written in English and provided eligible data. Studies were included when they compared USP26 mutations in azoospermic, oligozoospermic, and asthenozoospermic patients with controls with normal sperm parameter values or whose partners had experienced spontaneous pregnancy. Pooled odds ratio (OR) with 95% confidence interval (CI) was calculated with random effect models. Overall, twelve studies with 3927 infertility patients and 4648 healthy controls were included. The association between overall USP26 mutations and infertility was not significant (OR = 1.60, 95% CI: 0.51-5.01). For specific mutations, the pooled ORs were 1.65 (95% CI: 1.02-2.69) for cluster mutation (including 370-371insACA, 494T>C, and 1423C>T), 1.80 (95% CI: 0.35-9.15) for c.576G>A, 1.43 (95% CI: 0.79-2.56) for c.1090C>T, and 3.59 (95% CI: 2.30-5.59) for c.1737G>A. Our results suggest that several mutations (cluster mutation, c.1737G>A) may play roles in male infertility, while others (c.576G>A and c.1090C>T) do not show notable associations with male infertility. More high-quality clinical researches are needed for validation.

Keywords: azoospermia; haplotype; male infertility; mutation; ubiquitin-specific protease 26.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
Flow diagram of the included study in this meta-analysis.
Figure 2
Figure 2
Forest plot of the association between overall mutations of ubiquitin-specific protease 26 (USP26) and male infertility. CI: confidence interval; df: degrees of freedom; M–H: Mantel–Haenszel.
Figure 3
Figure 3
Forest plots of the association between variants of ubiquitin-specific protease 26 (USP26) and (a) male infertility and (b) cluster mutation of USP26 (c.576G>A). CI: confidence interval; df: degrees of freedom; M–H: Mantel–Haenszel.
Figure 4
Figure 4
Forest plots of the association between variants of ubiquitin-specific protease 26 (USP26) and male infertility: (a) c.1090C>T, (b) c.1737G>A. CI: confidence interval; df: degrees of freedom; M–H: Mantel–Haenszel.

References

    1. Duca Y, Calogero AE, Cannarella R, Condorelli RA, La Vignera S. Current and emerging medical therapeutic agents for idiopathic male infertility. Expert Opin Pharmacother. 2019;20:55–67. - PubMed
    1. Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2–10. - PubMed
    1. Shiraishi K. Genome medicine in male infertility: from karyotyping to single-cell analysis. J Obstet Gynaecol Res. 2021;47:2586–96. - PubMed
    1. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Jr, et al. Cancer genome landscapes. Science. 2013;339:1546–58. - PMC - PubMed
    1. Krausz C, Riera-Escamilla A. Genetics of male infertility. Nat Rev Urol. 2018;15:369–84. - PubMed

Substances